← Browse by Condition
Medical Condition

magnetic resonance imaging

Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for magnetic resonance imaging sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — magnetic resonance imaging Clinical Trials

How many clinical trials are currently recruiting for magnetic resonance imaging?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for magnetic resonance imaging, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for magnetic resonance imaging?
magnetic resonance imaging research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a magnetic resonance imaging clinical trial?
Eligibility criteria for magnetic resonance imaging trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
Mark Niciu 1 trial
Universitaire Ziekenhuizen KU Leuven 1 trial
University of Cagliari 1 trial
University of Pennsylvania 1 trial
Chinese PLA General Hospital 1 trial

Recruiting Clinical Trials

NCT02122562 Phase 2
Recruiting
Ketamine Alcohol (in Treatment-Resistant Depression)
Enrollment
60 pts
Location
United States
Sponsor
Mark Niciu
View Trial →
NCT05727605
Recruiting
Neurocognition After Radiotherapy in CNS- and Skull-base Tumors
Enrollment
120 pts
Location
Belgium
Sponsor
Universitaire Ziekenhuizen KU ...
View Trial →
NCT06277297
Recruiting
Prognotic Role of CMR in Takotsubo Syndrome
Enrollment
350 pts
Location
Italy
Sponsor
University of Cagliari
View Trial →
NCT07602270
Recruiting
Effects of Ketogenic Diet on Alcohol Intoxication
Enrollment
20 pts
Location
United States
Sponsor
University of Pennsylvania
View Trial →
NCT05122403
Recruiting
Multimodal MRI for MRgFUS Central Lateral Thalamotomy in Neuropathic Pain
Enrollment
12 pts
Location
China
Sponsor
Chinese PLA General Hospital
View Trial →
NCT07069452
Recruiting
Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke
Enrollment
152 pts
Location
France
Sponsor
Centre Hospitalier de Gonesse
View Trial →

Related Conditions

major depression (1) alcoholism (1) cognition (1) brain tumor (1) meningioma (1) glioma (1) pituitary adenoma (1) takotsubo cardiomyopathy (1) machine learning (1) ketogenic diet (1) alcohol drinking (1) alcohol use disorder (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology